Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring stereochemical control. Its protected hydroxyl and amine functionalities allow selective reactions in multi-step organic syntheses. Commonly employed in the preparation of protease inhibitors, kinase inhibitors, and other bioactive molecules where the pyrrolidine ring serves as a structural scaffold. The Boc-protected amine enables easy deprotection under mild acidic conditions, making it suitable for peptide-like couplings and solid-phase synthesis. Also utilized in the manufacture of drug candidates targeting central nervous system disorders and antiviral therapies.